- Home
- SGMT vs PAYS Comparison
SGMT vs PAYS Comparison
Compare SGMT & PAYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- PAYS
- Stock Information
- Founded
- SGMT 2006
- PAYS 1995
- Country
- SGMT United States
- PAYS United States
- Employees
- SGMT N/A
- PAYS N/A
- Industry
- SGMT
- PAYS Business Services
- Sector
- SGMT
- PAYS Consumer Discretionary
- Exchange
- SGMT Nasdaq
- PAYS Nasdaq
- Market Cap
- SGMT 159.0M
- PAYS 160.1M
- IPO Year
- SGMT 2023
- PAYS 1998
- Fundamental
- Price
- SGMT $4.39
- PAYS $3.04
- Analyst Decision
- SGMT Buy
- PAYS Strong Buy
- Analyst Count
- SGMT 6
- PAYS 3
- Target Price
- SGMT $23.00
- PAYS $6.17
- AVG Volume (30 Days)
- SGMT 1.2M
- PAYS 348.4K
- Earning Date
- SGMT 11-13-2024
- PAYS 11-05-2024
- Dividend Yield
- SGMT N/A
- PAYS N/A
- EPS Growth
- SGMT N/A
- PAYS 368.11
- EPS
- SGMT N/A
- PAYS 0.14
- Revenue
- SGMT N/A
- PAYS $56,467,600.00
- Revenue This Year
- SGMT N/A
- PAYS $25.57
- Revenue Next Year
- SGMT N/A
- PAYS $13.13
- P/E Ratio
- SGMT N/A
- PAYS $21.95
- Revenue Growth
- SGMT N/A
- PAYS 27.75
- 52 Week Low
- SGMT $2.39
- PAYS $2.48
- 52 Week High
- SGMT $20.71
- PAYS $5.59
- Technical
- Relative Strength Index (RSI)
- SGMT 44.30
- PAYS 47.64
- Support Level
- SGMT $4.06
- PAYS $2.95
- Resistance Level
- SGMT $7.38
- PAYS $3.40
- Average True Range (ATR)
- SGMT 0.63
- PAYS 0.20
- MACD
- SGMT -0.11
- PAYS 0.03
- Stochastic Oscillator
- SGMT 9.94
- PAYS 38.67
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. The company's lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).
About PAYS Paysign Inc.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized, payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.